AzTrials
AzTrials

Post-Acute COVID-19 SyndromeExPostCovid-19NCT06248151

Acute Cardiovascular Responses to a Single Exercise Session in Patients With Post-COVID-19 Syndrome

A study testing Exercise session in people with Post-Acute COVID-19 Syndrome, run by University of Nove de Julho at 1 site in Brazil.

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

The objective of the study is to compare the acute cardiorespiratory and perceptual responses to a physical exercise session in those infected by Covid-19 with and without persistent symptoms. Read more about this study

Who is it for?
Ages 18 years and olderHealthy volunteers can take part
Conditions the study is for
Post-Acute COVID-19 Syndrome
What is being tested?
Exercise session
Could I receive a placebo?
No, everyone receives an active treatment
How many people
40 participants
Where
1 siteBrazil
Study dates
15 Feb 2024to 30 Jul 2025
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Who may be able to join

  • Post-Covid Syndrome group:
  • have had a positive RT-PCR test for Covid-19;
  • present persistent symptoms of Post Covid 19 syndrome, which have no other health explanation according to the criteria of the World Health Organization (WHO);
  • have the cognitive and physical capacity to perform the exercises; It is
  • low cardiovascular risk classification according to the American College of Sports Medicine criteria.
  • Healthy group:
Show all 9Show fewer
  • not present persistent symptoms of Post Covid 19 syndrome, which have no other health explanation according to the criteria of the World Health Organization (WHO);
  • have the cognitive and physical capacity to perform the exercises; It is
  • low cardiovascular risk classification according to the American College of Sports Medicine criteria.

Who cannot join

None listed.

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Raphael Dias, PhD contact

+5519999406878

raphaelritti@gmail.com

Marilia Correia, PhD contact

+5511999711669

marilia.correia@live.com

Brazil1 site, 1 recruiting
  • Universidade Nove de Julho

    São Paulo, 01504-001

    Raphael Dias

    Recruiting

Other trials in Brazil

About this study

Official title: Acute Cardiovascular Responses to a Single Exercise Session in Patients With Post-Covid-19 Syndrome

The objective of the study is to compare the acute cardiorespiratory and perceptual responses to a physical exercise session in those infected by Covid-19 with and without persistent symptoms.

Read the detailed description

The study will be a crossover carried out in two groups (with and without persistent symptoms of Covid-19). Participants in both groups will undergo a control session and an exercise session and cardiorespiratory and perceptual responses will be obtained before, during and after the sessions. In the exercise session, participants will perform aerobic exercises, strength exercises and muscle stretching, while in the control session participants will remain seated. Blood pressure, heart rate, cardiac autonomic modulation, peripheral oxygen saturation, vascular function and perception of affect will be obtained.

Being tested
Exercise session, Control session
Keywords
Post-Covid 19 Syndrome, Covid-19, fatigue, cardiovascular system, respiratory system, rehabilitation
Medical subject headings
Post-Acute COVID-19 Syndrome, COVID-19, Fatigue

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Exercise sessionBehavioural

    Also called Rehabilitation, Cardiorespiratory exercises, Resistance exercises, Flexibility

    Session will included aerobic, resistance and flexibility exercises and will last approximately 45 minutes. The session will begin with aerobic exercises (5 min jumping jacks and 5 min stationary walking). Then, nine strength exercises will be performed for the main muscle groups (3 times of 12 to 15 repetitions, with a 1-minute rest interval) and finally stretching for the main muscle groups

  • Control sessionBehavioural

    Remain seated for 60 min

Study groups in NCT06248151
Study groupRoleWhat they receive
ExerciseExperimentalIn the exercise session, participants will perform aerobic, free active and flexibility exercises and will last approximately 45 minutes.
Receives: Behavioral: Exercise session; Behavioral: Control session
ControlOtherIn the control session, participants will remain seated for 60 minutes.
Receives: Behavioral: Exercise session; Behavioral: Control session

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Change in Blood pressure

    Assessment of the systolic and diastolic blood pressure using an automatic device

    Measured: Before and 30 and 50 minutes after the end of the exercise and control interventions

  2. Change in Heart rate variability

    Assessment of the heart rate variability indicators using a heart rate monitor

    Measured: Before and 30 and 50 minutes after the end of the exercise and control interventions

  3. Change in flow mediated dilation

    Assessment of the flow mediated dilation using a doppler ultrasound

    Measured: Before and 30 minutes after the end of the exercise and control interventions

  4. Change in peak exhalation flow

    Assessment of the peak exhalation flow using a peak flow device

    Measured: Before and 5 minutes after the end of the exercise and control interventions

  5. Change in oxygen saturation

    Assessment of the peripheral oxygen saturation using a pulse oximeter

    Measured: Before, during and 5 minutes after the end of the exercise and control interventions

Secondary outcomes (2)
  1. Change in heart rate

    Assessment of heart rate using a heart rate monitor

    Measured: Before and continuously during exercise and control interventions

  2. Change in affective response

    Assessment of affective response using a felling scale

    Measured: Before and every 5 minutes during exercise and control interventions

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted8 Feb 2024
  2. Study start15 Feb 2024
  3. Primary completion30 Dec 2024 (estimated)
  4. Study completion30 Jul 2025 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Crossover
Masking
Single blind
Who is masked
Outcomes assessor
Enrolment
40 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06248151
Sponsor's protocol ID
Acute_Covid
Other IDs
0057/2022
Acronym
ExPostCovid-19
Status last verified
Dec 2024
First submitted
6 Feb 2024
Last updated
4 Dec 2024
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Undecided: Plan to share the data after completion upon resonable request

Questions about this trial

What is this clinical trial studying?

A study testing Exercise session in people with Post-Acute COVID-19 Syndrome, run by University of Nove de Julho at 1 site in Brazil.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 9 inclusion and 0 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 4 Dec 2024. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Brazil. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Raphael Dias, PhD (+5519999406878, raphaelritti@gmail.com), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Change in Blood pressure (time frame: Before and 30 and 50 minutes after the end of the exercise and control interventions). The study lists 5 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 4 Dec 2024.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in